Revai has developed a technology platform for keeping organs healthier during transportation from donor to recipient. Based on this platform, the Intestinal Preservation Unit (IPU) was developed and is currently being tested with human grafts. Given that the method of ischemic reperfusion injury is similar across organs, we are looking to continue developing our technology in a market with challenging, unmet needs in a way that can be translated to other organs.
- Jesse Rich (SOM ‘16): Background in healthcare economics and finance.
- Jen Gaze (SOM ‘16): Experience launching disruptive new ventures.
- Dr. John Geibel: Professor of Surgery (Gastrointestinal) and of Cellular and Molecular Physiology; Vice Chair, Surgery; Director, Surgical Research; American Gastroenterological Association Fellow.
- Dr. Joe Zinter: Associate Research Scientist & Lecturer - Mechanical Engineering & Materials Science; Assistant Director, Center for Engineering Innovation & Design